Effect of Lateral Size of Graphene Quantum Dots on Their Properties and Application.

Well-defined graphene quantum dots (GQDs) are crucial for their biological applications and the construction of nanoscaled optoelectronic and electronic devices. However, as-synthesized GQDs reported in many works assume a very wide lateral size distribution; thus, their apparent properties cannot truthfully reflect intrinsic properties of the well-defined GQDs, and more importantly, the applications of GQDs will be affected and limited as well. In this work, we demonstrated that different sized GQDs with a narrow size distribution could be obtained via gel electrophoresis of the crude GQDs prepared through a photo-Fenton reaction of graphene oxide (GO). It is illustrated that the photoluminesce (PL) emissions of the well-defined GQDs originated mainly from the peripheral carboxylic groups and conjugated carbon backbone planes through fluorescence and UV-vis spectroscopies. More importantly, our findings challenge the notion that the excitation wavelength dependent PL property of the as-synthesized GQDs is the intrinsic property of the size-defined GQDs. Preliminary data at the cellular level indicated that the small sized GQDs exhibit weaker quenching DNA dye ability but higher toxicity to the cells compared to that of the as-synthesized GQDs. This discovery is essential to explore applications of the GQDs in pharmaceutics and to understand the origin of the optoelectronic properties of GQDs.

Enhancing cell nucleus accumulation and DNA cleavage activity of anti-cancer drug via graphene quantum dots.

Graphene quantum dots (GQDs) maintain the intrinsic layered structural motif of graphene but with smaller lateral size and abundant periphery carboxylic groups, and are more compatible with biological system, thus are promising nanomaterials for therapeutic applications. Here we show that GQDs have a superb ability in drug delivery and anti-cancer activity boost without any pre-modification due to their unique structural properties. They could efficiently deliver doxorubicin (DOX) to the nucleus through DOX/GQD conjugates, because the conjugates assume different cellular and nuclear internalization pathways comparing to free DOX. Also, the conjugates could enhance DNA cleavage activity of DOX markedly. This enhancement combining with efficient nuclear delivery improved cytotoxicity of DOX dramatically. Furthermore, the DOX/GQD conjugates could also increase the nuclear uptake and cytotoxicity of DOX to drug-resistant cancer cells indicating that the conjugates may be capable to increase chemotherapy efficacy of anti-cancer drugs that are suboptimal due to the drug resistance.